Novavax to Receive $350 Million from Canada for Unused COVID Shots

July 11th, 2023

Via: BNN:

Novavax Inc (NVAX.O) announced on Friday that it had reached an agreement with Canada, under which the country would pay $349.6 million to settle the forfeiting of certain doses of the company’s COVID-19 vaccine that were originally scheduled for delivery. This development comes as a result of a significant decrease in global demand for COVID-19 vaccines, leading to a surplus of unused doses.

Leave a Reply

You must be logged in to post a comment.